Inventor · disambiguated record
Thomas Charles Pertel
Also filed as: PERTEL THOMAS CHARLES
9 granted patents·8 pending applications·19 citations·filing 2015–2024
81Inventor score
Top patents by PatentIndex Score
17 records- 0192US10294304B2Chimeric antigen receptors targeting B-cell maturation antigenPFIZER·Filed 2016·Granted May 21, 2019·16 cites·22 claims
- 0284US11072644B2Inhibitory chimeric antigen receptorsALLOGENE THERAPEUTICS INC·Filed 2015·Granted Jul 27, 2021·2 cites·21 claims
- 0382US11312782B2Chimeric antigen receptors targeting B-cell maturation antigenPFIZER·Filed 2019·Granted Apr 26, 2022·1 cites·46 claims
- 0478US2024360196A1Inhibitory chimeric antigen receptorsALLOGENE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0576US12447178B2Method of treatment using anti-CD19 rituximab-resistant chimeric antigen receptorsALLOGENE THERAPEUTICS INC·Filed 2023·Granted Oct 21, 2025·0 cites·21 claims
- 0673US11912776B2Chimeric antigen receptors targeting B-cell maturation antigenPFIZER·Filed 2022·Granted Feb 27, 2024·0 cites·24 claims
- 0772US2025171731A1Methods of manufacturing allogeneic car t cellsALLOGENE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0869US2025207199A1Methods for detecting genomic abnormalities in cellsALLOGENE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0967US2022033462A1Inhibitory chimeric antigen receptorsALLOGENE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1064US2024003056A1Anti-talen antibodies and uses thereofALLOGENE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1161US11896617B2Polynucleotides encoding rituximab-resistant chimeric antigen receptorsALLOGENE THERAPEUTICS INC·Filed 2020·Granted Feb 13, 2024·0 cites·23 claims
- 1261US2023407252A1Methods for donor cell analysisALLOGENE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1360US12163153B2Methods of manufacturing allogeneic CAR T cellsALLOGENE THERAPEUTICS INC·Filed 2020·Granted Dec 10, 2024·0 cites·18 claims
- 1460US11781248B2Anti-TALEN antibodies and uses thereofALLOGENE THERAPEUTICS INC·Filed 2020·Granted Oct 10, 2023·0 cites·23 claims
- 1557US2024085403A1Method for inhibiting adventitious viral infectionALLOGENE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1651US11732041B2Antibodies against 4G7-derived chimeric antigen receptorsALLOGENE THERAPEUTICS INC·Filed 2020·Granted Aug 22, 2023·0 cites·29 claims
- 1744US2021062150A1Methods of preparing t cells for t cell therapyALLOGENE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →